About Medis
Medis is an established company specialising in out-licensing high-quality generic pharmaceuticals to third-parties. Founded in 1985, we pride ourselves on building strong and enduring business partnerships.
Medis draws on the development and manufacturing capabilities of its parent company, Teva Pharmaceutical Industries Ltd., whose research & development specialists maintain a strong development pipeline. Teva (NYSE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by millions of patients every day.
Medis' 35 years of experience and in-depth understanding of the generics sector attract regular business from around the world.
Medis has operations in Iceland, Germany, France, Spain, Italy, Australia, Poland, and Brazil and our customer base spans over 140 countries to date.
- Focus : Manufacturer
- Industry : Pharma
Here you will find Medis
Last viewed contents
Bloodroot
Causus_maculatus
Crucell Doubles Production of Quinvaxem in 2008 and Prepares Move to New Korean Production Site to Facilitate Growth
Health_insurance
In a role reversal, RNAs proofread themselves - Molecular photographs of an enzyme bound to RNA reveal a new, inherent quality control mechanism
HLC - Haep Labor Consult - Bovenden, Germany
Royal_College_of_Physicians
